Alessandro Blasimme

Cited by

	All	Since 2017
Citations	2004	1783
h-index	23	21
i10-index	39	34

540

270

135

405

201320142015201620172018201920202021202219 45 49 85 111 154 234 323 535 411

Public access

View all

19 articles

1 article

available

not available

Based on funding mandates

Co-authors

Effy VayenaETH ZurichVerified email at hest.ethz.ch
Marco CanevelliDepartment of Human Neuroscience, Sapienza University, Rome, ItalyVerified email at uniroma1.it
Giuseppe BrunoProfessore Associato, Università "Sapienza", RomaVerified email at uniroma1.it
Matteo CesariUniversità degli Studi di Milano, Milan, ItalyVerified email at unimi.it
Marcello IencaEPFLVerified email at epfl.ch
Bastian Greshake TzovarasFellow at CRI (Université de Paris, Inserm) & Director of Open HumansVerified email at bio.uni-frankfurt.de
"Glenn Cohen" "I.G. Cohen" "I. Glenn...Harvard Law SchoolVerified email at law.harvard.edu
Pierre-Luc GermainUniversity & ETH ZürichVerified email at hest.ethz.ch
Pasquale LaiseSenior Director of Single-Cell Systems Biology at DarwinHealth Inc.Verified email at darwinhealth.com
Giulia FragolaUNC at Chapel HillVerified email at med.unc.edu
Paolo MaugeriEuropean Institute of Oncology - University of MilanVerified email at ieo.eu
paola piscopoRicercatore, Istituto Superiore di Sanità, RomaVerified email at iss.it
Annamaria ConfaloniPrimo Ricercatore, Istituto Superiore di SanitàVerified email at iss.it
Giuseppina TalaricoDipartimento di Neurologia e Psichiatria- Università "Sapienza", RomaVerified email at uniroma1.it
Lisa BortolottiProfessor of Philosophy, University of BirminghamVerified email at bham.ac.uk
Alessandro CuomoIEOVerified email at ieo.eu
Tiziana BonaldiTenured Group Leader European Institute of OncologyVerified email at ieo.it
gabriele bucciIRCCS Ospedale San RaffaeleVerified email at hsr.it
Cesar SommerAllogene TherapeuticsVerified email at allogene.com
Stefano CasolaFIRC Institute of Molecular Oncology, IFOMVerified email at ifom.eu

Alessandro Blasimme

ETH Zurich

Verified email at inserm.fr

Bioethics


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Machine learning in medicine: addressing ethical challenges E Vayena, A Blasimme, IG Cohen PLoS medicine 15 (11), e1002689, 2018	294	2018
Explainability for artificial intelligence in healthcare: a multidisciplinary perspective J Amann, A Blasimme, E Vayena, D Frey, VI Madai BMC Medical Informatics and Decision Making 20 (1), 1-9, 2020	184	2020
Operational definition of active and healthy ageing (AHA): a conceptual framework J Bousquet, D Kuh, M Bewick, T Standberg, J Farrell, R Pengelly, ME Joel, ... The journal of nutrition, health & aging 19 (9), 955-960, 2015	96	2015
Biomedical big data: new models of control over access, use and governance E Vayena, A Blasimme Journal of bioethical inquiry 14 (4), 501-513, 2017	95	2017
Digital health: meeting the ethical and policy challenges E Vayena, T Haeusermann, A Adjekum, A Blasimme Swiss medical weekly 148, w14571, 2018	93	2018
Mapping the translational science policy ‘valley of death’ EM Meslin, A Blasimme, A Cambon-Thomsen Clinical and translational medicine 2 (1), 1-8, 2013	87	2013
Health research with big data: Time for systemic oversight E Vayena, A Blasimme Journal of Law, Medicine & Ethics 46 (1), 119-129, 2018	76	2018
Cell reprogramming requires silencing of a core subset of polycomb targets G Fragola, PL Germain, P Laise, A Cuomo, A Blasimme, F Gross, ... PLoS genetics 9 (2), e1003292, 2013	66	2013
Elements of trust in digital health systems: scoping review A Adjekum, A Blasimme, E Vayena Journal of medical Internet research 20 (12), e11254, 2018	64	2018
Open sharing of genomic data: Who does it and why? T Haeusermann, B Greshake, A Blasimme, D Irdam, M Richards, ... PLoS One 12 (5), e0177158, 2017	62	2017
What's next for COVID-19 apps? Governance and oversight A Blasimme, E Vayena Science 370 (6518), 760-762, 2020	60	2020
Data sharing for precision medicine: policy lessons and future directions A Blasimme, M Fadda, M Schneider, E Vayena Health Affairs 37 (5), 702-709, 2018	58	2018
Operational definition of active and healthy aging (AHA): the European innovation partnership (EIP) on AHA reference site questionnaire: Montpellier October 20–21, 2014, Lisbon … J Bousquet, J Malva, M Nogues, LR Mañas, B Vellas, J Farrell, M Bewick, ... Journal of the American Medical Directors Association 16 (12), 1020-1026, 2015	55	2015
Becoming partners, retaining autonomy: ethical considerations on the development of precision medicine A Blasimme, E Vayena BMC Medical Ethics 17 (67), 2016	47	2016
Familial Alzheimer's disease sustained by presenilin 2 mutations: Systematic review of literature and genotype–phenotype correlation M Canevelli, P Piscopo, G Talarico, N Vanacore, A Blasimme, A Crestini, ... Neuroscience & Biobehavioral Reviews 42, 170-179, 2014	41	2014
Regulation of cell-based therapies in Europe: current challenges and emerging issues A Blasimme, E Rial-Sebbag Stem cells and development 22 (S1), 14-19, 2013	41	2013
Big data and dementia: charting the route ahead for research, ethics, and policy M Ienca, E Vayena, A Blasimme Frontiers in medicine 5, 13, 2018	39	2018
Improving the measurement of scientific success by reporting a self-citation index JW Flatt, A Blasimme, E Vayena Publications 5 (3), 20, 2017	37	2017
Democratizing health research through data cooperatives A Blasimme, E Vayena, E Hafen Philosophy & Technology 31 (3), 473-479, 2018	33	2018
" Tailored-to-You": Public Engagement and the Political Legitimation of Precision Medicine A Blasimme, E Vayena Perspectives in Biology and Medicine 59 (2), 172-188, 2016	29	2016

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors